Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Breul

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Der Urologe. Ausg. A|October 23, 2014
[Complementary and alternative medicine]J Breul
Drug Safety|November 21, 2000
Antiandrogen withdrawal syndrome associated with prostate cancer therapies: incidence and clinical significanceR Paul, J Breul
Der Pathologe|June 6, 1998
[What does the urologist expect and hope for from the pathologist in diagnosis of prostate carcinoma]J Breul, R Hartung
Der Urologe. Ausg. A|May 1, 1998
[Anti-androgen withdrawal syndrome]J Breul, R Paul
Der Urologe. Ausg. A|January 1, 1994
[Reconstruction of the bladder neck after radical retropubic prostatectomy using a tubular bladder flap]J Breul, R Hartung
Der Urologe. Ausg. A|February 5, 2015
[Minimally invasive procedures to treat prostate cancer and renal cancer]J Breul, J W Thüroff
Der Urologe. Ausg. A|July 9, 2004
[Puncture of the common iliac vein during cystostomy]H van Randenborgh, J Breul
European Urology|January 1, 1995
Prostate-specific antigen density and age-specific prostate-specific antigen values: the solution of prostate cancer screening?R Paul, J Breul, R Hartung
The Journal of Urology|January 1, 1997
Extraprostatic production of prostate specific antigen is under hormonal controlJ Breul, U Pickl, J Schaff
European Journal of Medical Research|April 18, 1996
Enhancement of 5-fluorouracil cytotoxicity by folinic acid in different cell-lines of human renal cell carcinomaJ Breul, G Tief, R Hartung
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Der Urologe. Ausg. A|October 23, 2014
[Complementary and alternative medicine]J Breul
Drug Safety|November 21, 2000
Antiandrogen withdrawal syndrome associated with prostate cancer therapies: incidence and clinical significanceR Paul, J Breul
Der Pathologe|June 6, 1998
[What does the urologist expect and hope for from the pathologist in diagnosis of prostate carcinoma]J Breul, R Hartung
Der Urologe. Ausg. A|May 1, 1998
[Anti-androgen withdrawal syndrome]J Breul, R Paul
Der Urologe. Ausg. A|January 1, 1994
[Reconstruction of the bladder neck after radical retropubic prostatectomy using a tubular bladder flap]J Breul, R Hartung
Der Urologe. Ausg. A|February 5, 2015
[Minimally invasive procedures to treat prostate cancer and renal cancer]J Breul, J W Thüroff
Der Urologe. Ausg. A|July 9, 2004
[Puncture of the common iliac vein during cystostomy]H van Randenborgh, J Breul
European Urology|January 1, 1995
Prostate-specific antigen density and age-specific prostate-specific antigen values: the solution of prostate cancer screening?R Paul, J Breul, R Hartung
The Journal of Urology|January 1, 1997
Extraprostatic production of prostate specific antigen is under hormonal controlJ Breul, U Pickl, J Schaff
European Journal of Medical Research|April 18, 1996
Enhancement of 5-fluorouracil cytotoxicity by folinic acid in different cell-lines of human renal cell carcinomaJ Breul, G Tief, R Hartung
Pageof 4